They showed that xanthine oxidoreductase inhibits liver CSC survival and tumor promotion through interaction with ubiquitin-specific peptidase 15 which promotes deubiquitylation of KEAP1 leading to NRF2 degradation [141]. This evidence concerns the gene NFE2L2 and neoplasm.